MADISON, Wis., May 1, 2019 /PRNewswire/ -- Exact Sciences
Corp. (Nasdaq: EXAS) today announced that company management will
be presenting at the following investor conferences and invited
investors to participate by webcast.
- Bank of America Merrill Lynch Health Care Conference,
Las Vegas
Fireside Chat on May 15, 2019, at
4:00 p.m. EDT
- UBS Global Healthcare Conference, New
York
Fireside Chat on May 21, 2019, at
2:00 p.m. EDT
The webcast can be accessed in the investor relations section of
Exact Sciences' website at www.exactsciences.com.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused
on the early detection and prevention of some of the deadliest
forms of cancer. The company has exclusive intellectual property
protecting its non-invasive, molecular screening technology for the
detection of colorectal cancer. For more information, please visit
the company's website at www.exactsciences.com, follow Exact
Sciences on Twitter @ExactSciences or find Exact Sciences on
Facebook.
Forward-Looking Statements
This news release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that are intended to
be covered by the "safe harbor" created by those sections.
Forward-looking statements, which are based on certain assumptions
and describe our future plans, strategies and expectations, can
generally be identified by the use of forward-looking terms such as
"believe," "expect," "may," "will," "should," "would," "could,"
"seek," "intend," "plan," "goal," "project," "estimate,"
"anticipate" or other comparable terms. All statements other than
statements of historical facts included in this news release
regarding our strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking
statements. Examples of forward-looking statements include, among
others, statements we make regarding expected future operating
results, anticipated results of our sales and marketing efforts,
expectations concerning payer reimbursement and the anticipated
results of our product development efforts. Forward-looking
statements are neither historical facts nor assurances of future
performance. Instead, they are based only on our current beliefs,
expectations and assumptions regarding the future of our business,
future plans and strategies, projections, anticipated events and
trends, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ
materially from those indicated in the forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements. Important factors that could cause our actual results
and financial condition to differ materially from those indicated
in the forward-looking statements include, among others, the
following: our ability to successfully and profitably market our
products and services; the acceptance of our products and services
by patients and healthcare providers; our ability to meet demand
for our products and services; the willingness of health insurance
companies and other payers to cover our products and services and
adequately reimburse us for such products and services; the amount
and nature of competition from other cancer screening and
diagnostic products and services; the effects of the adoption,
modification or repeal of any law, rule, order,
interpretation or policy relating to the healthcare system,
including without limitation as a result of any judicial, executive
or legislative action; the effects of changes in pricing, coverage
and reimbursement for our products and services, including without
limitation as a result of the Protecting Access to Medicare Act of
2014; recommendations, guidelines and quality metrics issued by
various organizations such as the U.S. Preventive Services Task
Force, the American Cancer Society, and the National Committee for
Quality Assurance regarding cancer screening or our products and
services; our ability to successfully develop new products and
services; our ability to effectively utilize strategic
partnerships, such as our Promotion Agreement with Pfizer, Inc.,
and acquisitions; our success establishing and maintaining
collaborative, licensing and supplier arrangements; our ability to
maintain regulatory approvals and comply with applicable
regulations; and the other risks and uncertainties described in the
Risk Factors and in Management's Discussion and Analysis of
Financial Condition and Results of Operations sections of our most
recently filed Annual Report on Form 10-K and our subsequently
filed Quarterly Reports on Form 10-Q. We undertake no obligation to
publicly update any forward-looking statement, whether written or
oral, that may be made from time to time, whether as a result of
new information, future developments or otherwise.
Contact:
Megan
Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download
multimedia:http://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-may-investor-conferences-300841471.html
SOURCE EXACT SCIENCES CORP